chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 8 mins after receiving vaccine, complained of numbness to left side of face, gums and lateral tongue to midline.  No other symptoms of adverse reaction and vital signs were stable.  Numbness progressed from lateral aspect of tongue to midline so MD ordered Benadryl.  Symptoms resolve approx. 40 mins after Benadryl dose
prolonged crying (not high-pitched) persisting 5 1/2-6hr;
Dysautonomia, autonomic dysfunction, GERD, hyperinflamtion, suspicion of ME/CFS, suspicion of vaccine induced inflammatory response,  Doctors are still performing tests to determine larger extent of injury.  Immediate increase in heart pounding in chest/sharp pains in neck shoulder and down left arm.  Worsened with exercise.  Muscle twitching began a couple days after, starting in arms and moving to rest of body. Continued until onset of new symptoms beginning 8/14/2021. Starting 8/14/2021, began experience an array of different symptoms.  Started with tingling in lips and cold sores.  Sore and inflamed throat. Moved into flu-like symptoms over the next couple of days.  Chills, bad headache, chest pain, shortness
Painful Shingrix vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported.  The patient received vaccine and was painful.
Mom woke me up with her pulse at 134, 140, her BP about 160/90, she was out of breath, complained of chest pain, refused going to the ER.  I increased her Toprol b/c it had controlled her pulse when she developed A-fib in 2011. I was afraid to do it, so I increased it very little after I confirmed clinical protocol online, plus I know her condition well, but still I am not a physician. Very early in the morning with her cardiologist from home called me and told me to increase by half the Toprol dosage. He is her cardiologist when mom lives . It took almost a week to bring her pulse down to the 70's which is the ideal goal Dr.  set. Her feet remained swollen for  a few weeks. I am taking her to the  clinic to see her cardiologists there as well on July 7th.  PCP ordered two ekg's locally and her usual blood work-up for tikosyn  (every 90 days). We go once a year  because it was Doctor  who stabilized her back in 2011 with tikosyn. I drove her from out of state then to the clinic. She had had an awful adverse response to multaq . It almost killed her. My brother was traveling abroad an took her to my home. I had her hospitalized to have her pulse stabilized and then arranged the  clinic visit. Since then she has the yearly visits and her home cardiologist  supervised her care. She is very lucky to have such amazing physicians. This year was a bit different because of online health care, but now that we are vaccinated we are driving in.
whole body was aching; Sweating; Chills; I felt I had shutter glass all over my body; Strong headache/ headache that did not respond to any medication; Unable to concentrate, focus; Left under arm lymph node very swelled for over 10 days.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included graves. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 03:00, 16 hours after getting the second shot, the patient experienced whole body aching, sweating, chills and felt like the patient had shutter glass all over the body. These symptoms lasted for 4 days. The patient had a strong headache that last for 9 days, unable to concentrate, focus and a headache that did not respond to any medication and left under arm lymph node very swollen for over 10 days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the event headache and included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body aching, sweating, chills and felt like had shutter glass all over the body was recovered on 05Apr2021, strong headache that did not respond to any medication was recovered on 10Apr2021, left under arm lymph node very swollen was recovered on 11Apr2021 and the outcome of unable to concentrate, focus was unknown.  No follow-up attempts are needed. No further information is expected.
FELT HOT (NO TEMP), FATIGUE, INJECTION SITE PAIN  Narrative:  Other Relevant History:
Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Itching all over the body, has not subsided-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Unable to Sleep-Severe, Additional Details: Started the night of the shot per patient. Patient states that itching is all over; tingling all over. This itching and tingling has caused him to lose his job. His head is "going to explode" from the itching.
Employee received Moderna COVID vaccine on 12/24/2020. On 01/01/21, she developed cough, fever, neck pain, and HA. COVID PCR was negative on 01/02/2021. On 01/06/2021, she was evaluated in ED, and a lumbar puncture was consistent with aseptic meningitis. She received no medical treatment and was released to home. Did follow -up via telemed visit with PCP.
Stomach ache; Heart beat palpitation; Decreased apetite; Some lightheadedness; Headache; Muscle ache; Joint pain; Chills; Tiredness/ Extreme exhaustion; Injection site hurts / injection site is tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach ache), PALPITATIONS (Heart beat palpitation), DECREASED APPETITE (Decreased apetite), DIZZINESS (Some lightheadedness) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VENLAFAXINE HCL and VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), PALPITATIONS (Heart beat palpitation), DECREASED APPETITE (Decreased apetite), DIZZINESS (Some lightheadedness), HEADACHE (Headache), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Tiredness/ Extreme exhaustion) and VACCINATION SITE PAIN (Injection site hurts / injection site is tender to touch). At the time of the report, ABDOMINAL PAIN UPPER (Stomach ache), PALPITATIONS (Heart beat palpitation), DECREASED APPETITE (Decreased apetite), DIZZINESS (Some lightheadedness), HEADACHE (Headache), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Tiredness/ Extreme exhaustion) and VACCINATION SITE PAIN (Injection site hurts / injection site is tender to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Patient is 16 years old and received Moderna. Mother signed patient up in VRAS system for Covid 19 vaccine. Doctor called mother today 04/09/2021 to inform her who is not concerned and just wants to arrange patients 2nd dose.
Temp. 104.0 very lethargic, wouldn't eat barley taking fluids. Slept through the full exam. Wasn't talking, asked us to carry him to the bathroom to urinate.
This spontaneous report was received from a physician via a company representative and refers to a female patient of unknown age. The patient's pertinent medical history included unspecified kidney problems. No information regarding the patient's drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with a dose of unspecified pneumococcal vaccine (manufacturer unknown) (dose, route and site of administration, lot # and expiry date were not reported). Other suspect vaccines included influenza virus vaccine (unspecified) (date, dose, route and site of administration, lot # and expiry date were not reported). Concomitant therapies included ENBREL. On an unknown date, the patient was hospitalized for an unknown reason. The outcome of the event leading to hospitalization was not reported. On an unknown date, the patient died due to an unspecified cause. The relatedness between the events and pneumococcal vaccine (manufacturer unknown) and influenza virus vaccine (unspecified) was not reported. Upon internal review, the event of death was considered to be medically significant. Additional information has been requested.
Sore arm; Weak muscle; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th October 2020, the patient received the 1st dose of Shingrix. On 18th October 2020, several days after receiving Shingrix, the patient experienced pain in arm and muscle weakness. On an unknown date, the outcome of the pain in arm and muscle weakness were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and muscle weakness to be related to Shingrix.   Additional details were provided as follows: The age at vaccination was not reported. Nurse reported that the patient was administrated on the left arm with the dose of Shingrix.  The patient reported weak muscle and sore arm hours after the administration. The reporter consented to follow up. Lot number and expiration date are not available.
Caller reporting that after administering a dose of VAXNEUVANCE that the syringe experienced a break. He laid the syringe on the exam table gently after administration- vaccine was still in tact- and "2 seconds later the glass popped and broke.; Caller reporting that after administering a dose of VAXNEUVANCE that the syringe experienced a break. He laid the syringe on the exam table gently after administration- vaccine was still in tact- and "2 seconds later the glass popped and broke.; This spontaneous report was received from a nurse and refers to a 5-month-old male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 10-AUG-2023, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, 0.5 milliliter, valid lot #X005583, expiration date: 10-DEC-2024, administered intramuscularly for prophylaxis (strength was not provided) (Poor quality device used). Then, nurse stated that after administration of vaccine, he placed the safety on the needle. He laid the syringe on the exam table gently after administration (vaccine was still intact) and "2 seconds" later the glass popped and broke. The break occurred distal to the barrel of the syringe. The entire syringe tip/luer lock broke/snapped off into separate 2 pieces (Syringe issue). No additional information was provided.
This spontaneous report as received from a medical assistant refers to a 22 years old female patient. On 20-AUG-2014 the patient was vaccinated with a dose of GARDASIL (lot# J015378, expiry date: 09-APR-2016, dose, dose number, route of administration were not reported) that was improperly stored on 08-AUG-2014. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
65 yr old female presents with an adverse reaction to flu vaccine that she was mandated to have despite her PMH of adverse reaction to the flu vac            pt has vaccine on 11/22/19 then then next day started to have nausea as well as intense backpain then she had Brown urine - she did drink lots of water already but increased fluid intake and the next day urine was now yellow but still had nausea and then started to have more nausea and sinus discharge and cough with subsequent ribs out - 2 ribs out when saw chiropractor and said her immune system was very compromised from flu vaccine - pt also had severe headache now with nerve pain as well 4-5 days after the flu vaccination that then further progressed to joint pain that was extreme            she also went to see a medical doctor who said that her kidney and adrenals are/were greatly stressed from fighting the vaccination - the foreign material in her body            she also fell from nerve pain and muscle spasm and scraped her right shin and bruised it with gradually increase in redness and warm hot despite cleaning with soap water and otc anti-bacterial            she went back to her chiropractor on 12/9 and concern over leg wound and also immune system overload from flu vaccine
09:30 at injection day: Left arm pain started. 19:00 at injection day: Full-body pain started.  Couldn't fall asleep the whole night. Pain level moderate to severe. Left-arm pain expanded to whole upper left arm. 07:30 2nd day after injection: the first dose of ALEVE pain reliever (2 tablets, Naproxen Sodium tablets, 220mg), full-body pain disappeared temporarily.   15:30 2nd day after injection: previous medicines stopped working. Full-body pain restarted with a fever at approximately 38.5 degrees celsius.  Took another ALEVE tablet and 1 tablet of Tylenol Cold+Flu Severe (Acetaminophen 325mg, Dextromethorphan Hbr 10mg, Guaifenesin 200mg, Phenylephrine HCl 5mg).  23:30 2nd day after injection: Seems like the fever and full-body pain is still happening. Took 1 tablet of ALEVE and another 2 tablets of Tylenol.  08:30 3rd day after injection: No fever and full-body pain happening. Still have left arm pain but not whole upper left arm. 4th day after injection: about noon the left arm pain is totally gone.
Redness and swelling at the site 48 hours after given, assessed by provider with no treatment recommended. 4 days after given back/leg pain and weakness started making patient unable to sit/stand without assistance for 4 days. Moderate pain and fatigue continued for weeks after but resolved by 2/19/2021 and no further visit with provider were made.
Heart attack; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criterion medically significant). At the time of the report, MYOCARDIAL INFARCTION (Heart attack) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.  Company comment: This case concerns a 65-year-old male with a serious unexpected event of myocardial infarction, and nonserious diarrhea. Event latency 1 day after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Added new adverse event myocardial infarction and upgraded the case to serious.; Sender's Comments: This case concerns a 65-year-old male with a serious unexpected event of myocardial infarction, and nonserious diarrhea. Event latency 1 day after first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Dtap #4 given 1/22/07 to right deltoid. Developed swelling/redness, seen 1/24/07 with 6cm x 6cm erythema to right deltoid.  Started on Keflex/Motrin
Shoulder pain; limited mobility in arm; shooting and throbbing pain in arm based on movement.
approx 2hrs p/vax pt began screaming; It was high pitched & non-stop for 3hrs; pt also was rigid; pt was irritable w/frequent episodes fo crying for approx 24hrs;
Complete Lost hearing on left hear.  steroid injection and taking Prednisone for 5 days. Head Still cannot hear on left ear.
4:07p c/o pruritis, erythema at injection site, ice pack/3 tsp Benadryl 12.5 mg/5cc PO, 420p still c/o pruritis "weird" sensation in throat no resp difficulty, EMS notified 0.2cc Epinephrine SC L arm (1:1000)
Patient transferred from medical group practice for b/l PE. Patient reports chest pain and SOB x 4 days ago. Patient has also been having hemoptysis for the past couple days as well. Physical exam is remarkable for tachycardic heart rate and rhythm is regular. Patient given heparin bolus and infusion and admitted to hospital for acute large main vessel pulmonary embolism. 2D echocardiogram showing no signs of right heart strain.  Patient was transitioned to oral Eliquis and given a 1 month supply on discharge. Patient told to stop birth control and avoid NSAIDS. Patient instructed to F/U with PCP and hematology.
PERMANENT NEUROLOGICAL DAMAGE; MISERABLE LIFE OF PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: fibromyalgia. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced permanent neurological damage, and miserable life of pain. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the permanent neurological damage and miserable life of pain was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required per standard procedure as the case assessed as non-serious.
Severe muscle pain lasted over 50 days after booster dose of Moderna in 2/23/2022. I have stopped all medications including 10 mg Lipitor ,however the muscle pain continues weeks after
TC from mother. States pt felt tired post vaccines of 8/14/02 and c/o R arm soreness. At 5am felt hot was given Motrin. Temp taken about 3 pm oral 100.4.  Pt reported to mom body feels hot inside. Mother stated had sinus infection completed antibiotics one week ago. Mother advised could possibly be reaction to Hep B. Would be a good idea to consult with PMD. R arm soreness subsided had temp x 2 days and subsided. Back to normal.
The child started having tonic clonic type movements, then fell and hit his head and continued with tonic clonic type movements.  We activated EMS and child was taken to ED via ambulance.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided. Treatment medication was not reported.
Sore arm; She is pregnant and was accidently administered GARDASIL 9; She was supposed to receive a pfizer covid vaccine booster but the nurse made a mistake and administered GARDASIL 9; This spontaneous, prospective, pregnancy report has been received from a consumer referring to herself, a 39-year-old female. The patient's concurrent conditions, concomitant therapies, previous drug reactions or allergies were not reported.  On 18-OCT-2022, the patient was accidently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, once, administered intramuscularly on the left deltoid, administered as prophylaxis (dose and strength were not provided; lot number 1780878 had been verified to be a valid number: expiration date was reported and estalblished as on  02-DEC-2023) instead of a COVID vaccine booster (wrong product administered). At the time of the vaccination, the patient was 13 weeks and 2 days pregnant (exposure during pregnancy). Additionally, the patient experienced sore arm (pain in extremity).  On an unknown date, the patient was vaccinated with with tozinameran (PFIZER BIONTECH COVID-19 VACCINE).  The outcome of the event pain in extremity was not provided.  The causal relationship between the event pain in extremity and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not reported.
adverse events: sore around vaccination site, body aches (even toes), shivering, fever, tired, nausea, light-headed treatment: acetaminophen events went away on their own after  about 36 hours
Rash in crops over 3-4 days, pt not seen, sibling seen has chickenpox. Rash started around 12/28/04- by history.
This case was reported by a physician via call center representative and described the occurrence of creatine phosphokinase increased in a male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced creatine phosphokinase increased, erythema of extremities and increased white cell count. On an unknown date, the outcome of the creatine phosphokinase increased, erythema of extremities and increased white cell count were unknown. It was unknown if the reporter considered the creatine phosphokinase increased, erythema of extremities and increased white cell count to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the healthcare professional who himself was the patient. The health care professional reported that he experienced an increase in creatine phosphokinase (CPK) and white cell count as well as redness on his arm after receiving SHINGRIX. No additional information could be obtained because the health care professional had patients he had to see and appeared frustrated that he was on hold for so long in attempt to reach someone in medical information. The health care professional hung up abruptly.